SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,621,191 | -4.6% | 458,845 | -9.8% | 0.10% | -2.9% |
Q2 2023 | $58,272,929 | -40.7% | 508,845 | -28.6% | 0.10% | -52.8% |
Q1 2023 | $98,249,910 | +12.6% | 712,834 | +5.8% | 0.22% | -35.9% |
Q4 2022 | $87,286,643 | -35.9% | 673,612 | -45.3% | 0.34% | -23.4% |
Q3 2022 | $136,119,000 | +57.0% | 1,231,396 | +6.5% | 0.44% | +88.8% |
Q2 2022 | $86,684,000 | -5.6% | 1,156,396 | -1.6% | 0.23% | +26.6% |
Q1 2022 | $91,853,000 | -6.8% | 1,175,796 | +7.4% | 0.18% | +0.5% |
Q4 2021 | $98,605,000 | +1098.1% | 1,095,000 | +1130.3% | 0.18% | +1207.1% |
Q3 2021 | $8,230,000 | +218.9% | 89,000 | +345.0% | 0.01% | +40.0% |
Q4 2019 | $2,581,000 | – | 20,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |